M&A

M&A

Emcure Pharma’s European arm Tillomed acquires products from UK’s Manx Healthcare for Rs.218-Cr

BSE Announcement   Financial Express   Manx  

Luton, UK-based Tillomed Laboratories, a subsidiary of Pune-based, publicly listed Emcure Pharmaceuticals, is to acquire the pharmaceutical portfolio of UK-based Manx Healthcare and its subsidiaries, Manx Pharma and Manx Generics for GBP 19.7 million (INR 218 crore). Tillomed will acquire the Manx product portfolio, along with intellectual properties, dossiers, marketing authorisations, and relevant inventory.The transaction will involve an upfront payment of GBP 6.2 million, with the remainder to be paid as milestone payments over the next 18 months.Founded in 1996, Manx specialises in affordable healthcare, particularly in generics and over-the-counter (OTC) products for pain management, dental care, gut health, and infection.